Cleantech Transit Inc (CLNO)

Biomass is an organic matter that can be used to make fuels, chemicals and other products, as well as provide heat or electricity. For example, wood is one of the oldest and most commonly used examples of biomass. Burning it produces heat to give us warmth.
Other sources include plants, aquatic plants, animal waste, organic compounds from municipal and industrial waste, which can be used to produce fuels and chemicals, as well as power. Biomass resources can be replenished through cultivation of energy crops such as fast growing trees and grasses.
Unlike other renewable energy sources, biomass can be converted directly into liquid fuels for our transportation needs. The two most common bio-fuels are ethanol and bio-diesel.

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

For more information about CLNO, visit www.cleantechtransitinc.com

*************************************

Art's-Way Manufacturing Co. Inc. (Nasdaq:ARTW) announced it has signed a formal Letter of Intent (LOI) to acquire Imperial Steel Tank Company. Based in Frankfort, Illinois, near Chicago, Imperial Steel Tank Company is a leader in the fabrication of American Society of Mechanical Engineers (ASME) pressure vessels. They make a variety of pressure vessels, storage tanks, heat exchangers, hazardous chemical tanks, half pipe jackets, manways including both bolted-style and quick-open, and provide custom designed vessels. Imperial's ASME pressure vessel designs have successfully solved complex process containment problems in the chemical and petrochemical industries, the food processing industry, pharmaceutical industry, and water and waste treatment sector.

Art's-Way Manufacturing Co., Inc., together with its subsidiaries, engages in the manufacture and sale of agricultural equipment in the United States.

******************************************

Power3 Medical Products, Inc (PWRM)

Alzheimer Disease was discovered in 1907 by Alois Alzheimer, but was not considered a major disease or disorder until the 1970s. Alzheimer documented a case of a woman in her fifties who exhibited severe cognitive disorders pertaining to memory, language, and social interaction.
After the patient's death, Alzheimer performed an autopsy on her brain, using a silver staining technique that allowed him to visualize the presence of neurons. In the process he found unusual formations, now known as senile plaques and neurofibrillary tangles. Alzheimer hypothesized that these lesions might be the cause or effect of the as yet to be named Alzheimer's disease, or possibly a combination of the two. The disorder was later named for Alzheimer as more people were found to have the symptoms associated with his findings.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3 Medical's diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer's disease and Parkinson's disease.

For more information about Power3 Medical Products, Inc. visit its website http://www.power3medical.com

******************************************

Glen Burnie Bancorp (Nasdaq:GLBZ), parent company of The Bank of Glen Burnie, announced that on June 9, 2011 its Board of Directors declared a regular dividend of ten cents ($0.10) per share of common stock. This action marks the company's 76th consecutive dividend. The regular dividend is payable on July 7, 2011 to shareholders of record at the close of business on June 24, 2011. As of June 8, 2011, Glen Burnie Bancorp had 2,707,866 common shares outstanding with approximately 422 shareholders of record.

Glen Burnie Bancorp operates as the holding company for The Bank of Glen Burnie that provides commercial and retail banking services to individuals, associations, partnerships, and corporations.

******************************************

DemandTec, Inc. (Nasdaq:DMAN) announced financial results for the first quarter of fiscal year 2012 ended May 31, 2011. Revenue was $22.5 million in the first quarter of fiscal 2012, compared to $18.0 million in the first quarter of fiscal 2011 and $22.3 million in the fourth quarter of fiscal 2011.GAAP gross profit was $13.5 million in the first quarter of fiscal 2012, compared to a gross profit of $10.9 million in the first quarter of fiscal 2011. Loss from operations was $7.0 million in the first quarter of fiscal 2012, compared to a loss from operations of $5.9 million in the first quarter of fiscal 2011.

DemandTec, Inc. provides collaborative optimization network of software services connecting retailers and consumer products (CP) companies.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings, Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you're looking for a multi display computer to enhance your trading then you'll want to visit www.crowntradingsystems.com